-
公开(公告)号:US20200048362A1
公开(公告)日:2020-02-13
申请号:US16279113
申请日:2019-02-19
申请人: ImmunoGen, Inc. , Genentech, Inc.
IPC分类号: C07K16/30 , A01K67/027 , C12N15/85 , A61K47/68 , A61K39/395 , C07K16/28 , A61K9/00 , C07K16/32
摘要: The application concerns methods of treatment using anti-ErbB receptor antibody-maytansinoid conjugates, and articles of manufacture suitable for use in such methods. In particular, the invention concerns ErbB receptor-directed cancer therapies, using anti-ErbB receptor antibody-maytansinoid conjugates.
-
公开(公告)号:US20170106097A1
公开(公告)日:2017-04-20
申请号:US15170401
申请日:2016-06-01
申请人: IMMUNOGEN, INC. , GENENTECH, INC.
IPC分类号: A61K39/00 , C07K16/32 , A61K31/5365 , A01K67/027 , A61K9/00 , C07K16/30
CPC分类号: C07K16/3015 , A01K67/0271 , A01K67/0275 , A01K67/0278 , A01K2207/15 , A01K2217/00 , A01K2217/05 , A01K2217/052 , A01K2227/105 , A01K2267/0331 , A61K9/0019 , A61K39/39558 , A61K47/6803 , A61K47/6855 , A61K47/6871 , A61K2039/505 , C07K16/2863 , C07K16/32 , C07K2317/24 , C12N15/8509
摘要: The application concerns methods of treatment using anti-ErbB receptor antibody-maytansinoid conjugates, and articles of manufacture suitable for use in such methods. In particular, the invention concerns ErbB receptor-directed cancer therapies, using anti-ErbB receptor antibody-maytansinoid conjugates.
-